3[2]Bastholt L, Dalmark M, Gjedde SB, et al. Dose-respose relationship of epirubicin in the treament of postmenopausal patients with metastatic breast cancer: A randomized study of epirubicin at four different dose levels pen formed by the Danish Br east Cancer Cooperative Gtoup[J] .J Clin 0ncol,1996,14:1146 ～ 1155.
4[3]Focan C, Andrien JM, Closon MT, et al. Dose-response relationship of epirubicin- based first-line chemotherapy for advanced breast cancer:A prospective randomized trial[J] .J Clin Oncol, 1993,11:1253 ～1263.
